制造基于hPSC的产品的计划用于AMD和PD
Lei Wang1,2,3, Yu-Kai Wang1,2,3, Da Li1,2,3
1National Stem Cell Resource Centre, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Advances in experimental medicine and biology
|October 24, 2025
概括
人类多能干细胞 (hPSCs) 可以产生用于再生医学的专门细胞. 这项研究详细介绍了创造视网膜色素表皮和中脑多巴胺基神经元的方法,用于治疗诸如黄斑变性和帕金森病等疾病.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 多能干细胞 (hPSCs) 由于其自我更新和分化能力,为细胞替代疗法提供了潜力.
- 像黄斑变性和帕金森病这样的退行性疾病是由于特定的细胞损失造成的,并且很难用传统方法治疗.
- 视网膜色素表皮 (RPE) 和中脑多巴胺基神经元 (mDA) 对于视力和运动控制分别至关重要.
研究的目的:
- 总结hPSC衍生的RPE和mDA神经元的分化和质量控制策略.
- 突出这些细胞在治疗与年龄相关的黄斑变性 (AMD) 和帕金森病 (PD) 的潜力.
- 将这些细胞疗法作为中国第一个干细胞临床研究项目的例子.
主要方法:
- 总结hESC衍生的RPE和mDA神经元的分化协议.
- 详细介绍了这些差异化的细胞类型的质量控制措施.
- 审查用于AMD和PD的细胞替代疗法方法.
主要成果:
- 来自hPSC的RPE和mDA神经元显示出作为细胞替代疗法的前景.
- 这些细胞类型是中国早期干细胞临床研究的组成部分.
- 确定的差异化和质量控制策略对于治疗开发至关重要.
结论:
- 来自hPSC的RPE和mDA神经元代表了再生医学的重大进步.
- 使用hPSC的细胞替代疗法具有治疗以前难以治疗的疾病的潜力.
- 持续的研究和开发对于将这些疗法转化为临床实践至关重要.
关键词:
与年龄相关的黄斑变性 (AMD)生物加工是一种生物加工.细胞分化的细胞分化.替代细胞的替代细胞细胞疗法是一种细胞疗法.标志性描述 标志性描述功能衍生品 功能衍生品制造业 制造业 制造业 制造业中脑的多巴胺基神经元 (mDAs)帕金森病 (PD) 是一种疾病.多能干细胞是多能干细胞.质量控制 质量控制视网膜色素上皮质 (RPE) 是一种更多相关视频
相关概念视频
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K


